Clinical Trial Update: Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALL [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial is exploring precision diagnosis directing HDAC inhibitors and tyrosine kinase inhibitors for adult Philadelphia-like acute lym…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Leukemia Acute
• Leukemia B-cell
• Leukemia Lymphoblastic

Drugs mentioned

• HDAC inhibitors (histone deacetylase inhibitors)
• TKIs (tyrosine kinase inhibitors)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Leukemia, Leukemia, Acute | Phase 2, Phase 3 | Status: UNKNOWN